Rhenman & Partners Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-268,000
| Closed | -$6.82M | – | 93 |
|
|
2024
Q3 | $6.82M | Buy |
268,000
+83,500
| +45% | +$2.13M | 0.55% | 57 |
|
|
2024
Q2 | $4.67M | Buy |
184,500
+80,000
| +77% | +$2.03M | 0.45% | 56 |
|
|
2024
Q1 | $3.23M | Sell |
104,500
-30,500
| -23% | -$943K | 0.31% | 65 |
|
|
2023
Q4 | $5.45M | Hold |
135,000
| – | – | 0.54% | 58 |
|
|
2023
Q3 | $3.56M | Hold |
135,000
| – | – | 0.38% | 61 |
|
|
2023
Q2 | $2.32M | Hold |
135,000
| – | – | 0.24% | 72 |
|
|
2023
Q1 | $2.32M | Buy |
+135,000
| New | +$2.32M | 0.25% | 74 |
|